Article
Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
Journal of human genetics - 1 Mar 2020
Kim Hyun-Ki, Lee Eun Jin, Lee Young-Jae, Kim Jisun, Kim Yongsub, Kim Kyunggon, Lee Shin-Wha, Chang Suhwan, Lee Young Joo, Lee Jong Won, Lee Woochang, Chun Sail, Son Byung Ho, Jung Kyung Hae, Kim Yong-Man, Min Won-Ki, Ahn Sei-Hyun
Abstract excerpt
The clinical utility of BRCA1/2 genotyping was recently extended from the selection of subjects at high risk for hereditary breast and ovary cancer to the identification of candidates for poly (ADP-ribose) polymerase (PARP) inhibitor treatment. This underscores the importance of accurate interpretation of BRCA1/2 genetic variants and of reducing the number of variants of uncertain significance (VUSs). Two recent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
